Xenetic Biosciences, Inc. (XBIO) SEC Filings — 2024
16 SEC filings for Xenetic Biosciences, Inc. (XBIO) in 2024.
Filings
- Xenetic Biosciences Files 8-K on Security Holder Vote — 8-K · Dec 13, 2024
- Xenetic Biosciences Files 8-K on Financials — 8-K · Nov 13, 2024
- Xenetic Biosciences Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Xenetic Biosciences Enters Material Definitive Agreement — 8-K · Nov 7, 2024
- Xenetic Biosciences Announces Leadership and Compensation Changes — 8-K · Oct 31, 2024
- Xenetic Biosciences Files 8-K on Financials — 8-K · Aug 14, 2024
- Xenetic Biosciences Q2 2024: Revenue Up, Net Loss Widens — 10-Q · Aug 13, 2024
- Xenetic Biosciences Appoints New Directors, Adjusts Executive Pay — 8-K · Jun 21, 2024
- Xenetic Biosciences Appoints New CMO & CSO, CMO Departs — 8-K · May 22, 2024
- Xenetic Biosciences Files 8-K on Financials — 8-K · May 10, 2024
- Xenetic Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Xenetic Biosciences Files Amendment to Annual Report — 10-K/A · Apr 26, 2024
- Xenetic Biosciences Files 8-K on Financials — 8-K · Mar 22, 2024
- Xenetic Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- CLS Therapeutics Amends 13D Filing for Xenetic Biosciences — SC 13D/A · Mar 18, 2024
- Xenetic Biosciences (XBIO) Announces Private Placement of Stock & Warrants — 8-K · Feb 12, 2024